April 18, 2023 06:18 AM EDTUpdated 11:55 AM
Deals

GSK will buy Bel­lus Health for $2B, set­ting up show­down with Mer­ck

Amber Tong

Lei Lei Wu

News Reporter

GSK is dish­ing out $2 bil­lion to ac­quire Bel­lus Health, the British phar­ma gi­ant an­nounced Tues­day morn­ing, stok­ing more M&A buzz amid a wide­spread …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

A service from the Financial Times